SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-009136
Filing Date
2021-05-06
Accepted
2021-05-05 18:24:20
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aeri-20210331.htm   iXBRL 10-Q 1123285
2 EX-31.1 aeri3312021ex311.htm EX-31.1 12462
3 EX-31.2 aeri3312021ex312.htm EX-31.2 12456
4 EX-32.1 aeri3312021ex321.htm EX-32.1 7290
5 EX-32.2 aeri3312021ex322.htm EX-32.2 7232
11 aeri-20210331_g1.jpg GRAPHIC 13447
12 aeri-20210331_g2.jpg GRAPHIC 13674
  Complete submission text file 0001628280-21-009136.txt   5681693

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20210331.xsd EX-101.SCH 38589
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20210331_cal.xml EX-101.CAL 75024
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20210331_def.xml EX-101.DEF 212598
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20210331_lab.xml EX-101.LAB 512868
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20210331_pre.xml EX-101.PRE 337045
13 EXTRACTED XBRL INSTANCE DOCUMENT aeri-20210331_htm.xml XML 932801
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 21895016
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences